In a landmark move, the FDA has announced plans to phase out animal testing requirements for monoclonal antibodies (mAbs) and other therapeutics, marking a significant shift in drug development. This…
Abstract Pharmaceutical developers are encouraged to adopt the best practices of being purposefully thoughtful about the use of animals, seeking alternatives wherever possible. They should engage with health authorities to…
Abstract Vaccines must provide effective protection against disease without any harmful side effects. Antigen purity is a crucial factor which until now has had to be tested on animals. However,…